News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO News>YSB Passes HKEX Listing Hearing
HKEX information revealed that YSB Inc., a digital pharmaceutical platform serving businesses outside of hospitals in China, has passed the listing hearing. Its sole sponsor is CIC...
Reset
Send
The window will close in 5 seconds
<IPO News>YSB Passes HKEX Listing Hearing
Close
Recommend
15
Positive
8
Negative
14
 
SHORT SELL
 
STOCK INFO

HKEX information revealed that YSB Inc., a digital pharmaceutical platform serving businesses outside of hospitals in China, has passed the listing hearing. Its sole sponsor is CICC. According to foreign media reports last year, YSB intends to raise USD300 million to USD500 million.

The company expected the proceeds from the listing to be used for further development of its pharmaceutical circulation business, further development of other businesses, research and development, and for working capital and general corporate purposes.

Related NewsM Stanley's Latest Focus List for H Shrs/CN ADRs/ A Shrs (Table)
YSB's revenue in 2022 was RMB14.275 billion, up 41.4% YoY, while its loss in 2022 widened to RMB1.489 billion from RMB494 million in 2021. The company's shareholders include FOSUN PHARMA (02196.HK)  +0.600 (+3.750%)    Short selling $35.84M; Ratio 13.815%   , Tiger Global Fund and Meta Group Limited, which is owned by HOPSON DEV HOLD (00754.HK)  +0.070 (+2.288%)    Short selling $642.31K; Ratio 11.087%   founder Chu Mang Yee.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-04 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.